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Otitis Media (OM), an infection in the space behind the
ear drum, is one of the most common childhood infectious
diseases worldwide. More than 70% of all children have at
least one middle ear infection by the age of six years. Among
them, approximately 5–10% of patients turn to chronic OM
which eventually causes hearing loss and sequelae.
The pathogenesis of chronic and/or recurrent OM are
multifactorial, including genetic predisposition, dysfunction
of the Eustachian tube, impairment of the mucociliary
system, hyperproduction of mucins, metaplasia/hyperplasia
of mucous cells, and active secretion of ions and water. No
matter what contributes to the development of the disease,
mucin production and mucous cell metaplasia/hyperplasia
are always problems in this disease.
Mucous cell metaplasia/hyperplasia occur in the middle
ear mucosa and tend to drive OM into a chronic status,
leading to abundant production and accumulation of mucus
in the middle ear cavity. Under the circumstances, this leads
tothedevelopmentofanOMentity,thatis,OMwithmucoid
eﬀusion. Mucous cell metaplasia/hyperplasia is frequently
associated with chronic purulent otorrhea when the tym-
panic membrane is performed, making OM irreversible and
intractable. However, it is unclear how this event initiates at
an acute setting of OM and deteriorates in the chronic stage
of OM.
In this particular issue, there are seven papers in total,
covering the clinical areas and basic sciences relevant to
OM. In the clinical areas, there are ﬁve papers, dealing with
application of auditory brainstem response in the operating
room, measuring thickness of middle ear mucosa with MRI
and CT, hearing loss in cleft palate patients, otoacoustic
emissions in children with OM with eﬀusion, and appraisal
of pneumococcal vaccine trials. In the basic sciences, there
are two review articles, focusing on the role of Atoh1 in
mucous cell metaplasia and mucin production and mucous
cell metaplasia/hyperplasia, respectively.
In these two review articles, what has been discussed
includes the cellular events through which mucous cells are
induced from general epithelial stem cells; bacterial metabo-
lites/inﬂammatory cytokines that modulate the development
of mucous cells in the middle ear, transcription factors and
other molecules that are responsible for diﬀerentiation of
mucous cells in the middle ear, possible factors that increase
the risks for mucous cell metaplasia/hyperplasia, and signal
pathways that are involved in the mucin disorders and
mucous cell metaplasia/hyperplasia.
Jizhen Lin
Joseph E. Kerschner
Per Cay´ e-Thomasen
Tetsuya Tono
Quan-An Zhang